닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[361.3]

2,144건 중 1,000건 출력

, 9/100 페이지

  • 81
    KEYNOTE-361: Phase 3 trial of pembrolizumab ± chemotherapy versus chemotherapy alone in advanced urothelial cancer
    Powles, T.; Loriot, Y.; Gschwend, J.E.; Bellmunt, J.; Geczi, L.; Vulsteke, C.; Abdelsalam, M.; Gafanov, R.; Kyun Bae, W.; Revesz, J.; Yamamoto, Y.; Anido, U.; Su, W.; Fleming, M.; Markus, M.; Feng, D.; Poehlein, C.; Alva, A.; ; (European urology supplements : official journal of the European Association of Urology, v.17, 2018, pp.e1147-e1148)
  • 82
    Corrigendum to “On 3-dimensional complex Hom-Lie algebras” [J. Algebra 555 (2020) 361–385]
    Garcí a-Delgado, R.; Salgado, G.; Sá nchez-Valenzuela, O.A.; Centro de Investigació n en Matemá ticas, A.C., Unidad Mé rida; Fac. de Ciencias, UASLP; Centro de Investigació n en Matemá ticas, A.C., Unidad Mé rida; (Journal of algebra, v.562, 2020, pp.286-289)
  • 83
    MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway
    Hua, Bin; Li, Yao; Yang, Xin; Niu, Xiaojuan; Zhao, Yanyang; Zhu, Xiaoquan; Breast Center, BeijingInstitute of Geriatrics National Health Commission, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; Breast Center, BeijingInstitute of Geriatrics National Health Commission, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; Breast Center, BeijingInstitute of Geriatrics National Health Commission, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; Breast Center, BeijingInstitute of Geriatrics National Health Commission, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics National Health Commission, Beijing Hospit; (Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, v.125, 2020, pp.109994)
  • 84
    P3-361: Microglial activation by fibrillar amyloid-beta peptides requires toll-like receptor 2
    Jana, M.; Pahan, K.; ; (Alzheimer's & dementia : the journal of the Alzheimer's Association, v.4, 2008, pp.T627)
  • 85
    (361)アントラキノン誘導体に関する研究 (第3報) アシルアミノアントラキノンの合成
    Hayashi, Takayuki; Fujino, Yoshimichi; ; (工業化學雜誌 = Journal of the Chemical Society of Japan, industrial chemistry section, v.57, 1954, pp.824-826)
  • 86
    361.3: Revised Siplizumab-based conditioning regimen for combined kidney and bone marrow transplantation improved mixed hematopoietic chimerism with significant enrichment of regulatory T cells.
    Otsuka, Ryo; Riella, Leonardo V; Spitzer, Thomas; Crisalli, Kerry; Baysa, Gabriel; Naso, Dana; Reeves, Patrick; Benedict Cosimi, A; Elias, Nahel; Kawai, Tatsuo; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA, United States.; Legorreta Center for Clinical Transplant Tolerance, Massachusetts General Hospital, Boston, MA,; (Transplantation, v.108, 2024, )
  • 87
    ChemInform Abstract: Steroids. Part 361. Derivatives of 5α‐Androstan‐3α‐ and 3. beta.‐ol with Acrylonitrile Side Chain.
    POUZAR, V.; CHODOUNSKA, H.; CERNY, I.; DRASAR, P.; ; (Chem Inform, v.23, 1992, pp.chin.199214284)
  • 88
    Abstract 145: MicroRNA-361-3p functions as an oncogenic microRNA in human oral cancer cells
    Tanaka, Hiroshi; Nakashiro, Koh-ichi; Oka, Ryota; Nishikawa, Yukiko; Goda, Hiroyuki; Hamakawa, Hiroyuki; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.71, 2011, pp.145-145)
  • 89
    MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway
    Tian, Lei; Zhao, Zhifeng; Xie, Ling; Zhu, JinPeng; Department Gastroenterol, Jinzhou Medical University, Affilliated Hospital 1, Jinzhou 121000, Liaoning Province, Peoples Republic of China; Department Gastroenterol, Zhongguo Medical University, Affilliated Hospital 4, Shengyang 110000, Liaoning Province, Peoples Republic of China; Department Anatomy, Jinzhou Medical University, Jinzhou 121000, Liaoning Province, Peoples Republic of China; Department Gastroenterol, Jinzhou Medical University, Affilliated Hospital 1, Jinzhou 121000, Liaoning Province, Peoples Republic of China; (Oncotarget, v.9, 2018, pp.4886-4896)
  • 90
    Circular RNA UBAP2 contributes to tumor growth and metastasis of cervical cancer via modulating miR-361-3p/SOX4 axis
    Meng, Lingli; Jia, Xiupeng; Yu, Wenying; Wang, Chunnian; Chen, Jie; Liu, Fenglei; Department of Histopathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315021 Zhejiang China; Department of Histopathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315021 Zhejiang China; Department of Histopathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315021 Zhejiang China; Department of Histopathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315021 Zhejiang China; Department of Experimental Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo, 315021 Zhejiang China; Department of Pathology, Gansu Provincial Hospital, No. 204, Donggang West Road, Chengguan District, Lanzhou, 730000 Gansu China; (Cancer cell international, v.20, 2020, pp.357)

처음 오셨나요?